2015
DOI: 10.1089/vim.2014.0090
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral Activity of Chloroquine Against Dengue Virus Type 2 Replication inAotusMonkeys

Abstract: Dengue virus (DENV) of the Flaviviridae family is a single positive-stranded RNA virus that is transmitted by Aedes aegypti and Aedes albopictus mosquitoes. The objective of this study was to investigate the use of chloroquine (CLQ) as an antiviral drug against dengue virus in monkeys. To analyze the action of the drug in vivo, nonhuman primates groups (Aotus azarai infulatus) were inoculated with a subcutaneous injection of a virulent strain of DENV-2, treated and untreated CLQ. Blood hematological, viremia, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
53
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(55 citation statements)
references
References 40 publications
2
53
0
Order By: Relevance
“…Two clinical trials specifically aimed at addressing chloroquine efficacy on acute phase of chikungunya virus infection were concluded with contrasting results [69]. On the other hand, chloroquine seems to be effective in vivo, at least in the mouse model, in inhibiting the human coronavirus subtype OC43 and EBOV [45,46], as well as in the Aotus monkeys, affecting the dengue virus type 2 replication [83].…”
Section: Antimalarial Drugsmentioning
confidence: 99%
“…Two clinical trials specifically aimed at addressing chloroquine efficacy on acute phase of chikungunya virus infection were concluded with contrasting results [69]. On the other hand, chloroquine seems to be effective in vivo, at least in the mouse model, in inhibiting the human coronavirus subtype OC43 and EBOV [45,46], as well as in the Aotus monkeys, affecting the dengue virus type 2 replication [83].…”
Section: Antimalarial Drugsmentioning
confidence: 99%
“…Chloroquine and its derivative hydroxychloroquine are such alkalizers and are used clinically as anticancer drugs or antimalarial candidate medicines (Vakifahmetoglu-Norberg et al, 2015). Chloroquine had inhibitory effects on flavivirus replication in vitro and significantly decreased Dengue virus type 2 replication in Aotus monkeys (Farias et al, 2015), but it did not reduce the duration of viral infection in a human clinical trial and showed several adverse effects, primarily vomiting (Tricou et al, 2010). More importantly, chloroquine seems not to be related with the equilibrium between degradative autophagy and secretory autophagy (Figure 1 and Table 1).…”
Section: Autophagy Inhibitors and The Clinical Effectsmentioning
confidence: 99%
“…However in this study, only marginal protection was observed with chloroquine against RRV. Different inhibitory mechanisms of chloroquine involves prevention of viral endocytosis (Khan et al, 2010), decrease in concentration of cytokines like TNF-␣, IFN-␥ that are associated with disease severity and decrease in systemic levels of a liver enzyme (Aspartate aminotransferase) (Farias et al, 2015). In contrast, ribavirin, a broad spectrum antiviral inhibits inosine monophosphate dehydrogenase (IMPDH), thus depleting intracellular GTP pool (Takhampunya et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Ribavirin and Chloroquine are widely used antivirals for several families of viruses. Antiviral effect of chloroquine has been reported against several viruses including Chikungunya virus, Hepatitis C virus, Crimean-Congo Haemorrhagic fever virus, Human Immunodeficiency virus, Selmiki forest virus, SARS coronavirus (Khan et al, 2010;Farias et al, 2015;Helenius et al, 1982). Similarly, Ribavirin has been shown to inhibit Dengue virus, Chikungunya virus, Orthopoxviruses, Hantaan virus, Bornavirus, Canine Distemper virus etc (Smee et al, 2001;Takhampunya et al, 2006).…”
Section: Introductionmentioning
confidence: 98%